Clinical Trials Directory

Trials / Unknown

UnknownNCT04928560

Diagnosis of Superficial Lymphadenopathy

SMI and CEUS in the Diagnosis of Superficial Lymphadenopathy

Status
Unknown
Phase
Study type
Observational
Enrollment
500 (estimated)
Sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to study the application of CEUS and SMI technology in superficial lymph node lesions (metastasis, lymphoma, inflammation, etc.), and to provide some diagnostic ideas for non-invasive diagnosis of lymph node lesions.

Detailed description

CEUS and SMI technology were used to evaluated the superficial lymph node lesions (metastasis, lymphoma, inflammation, etc.), and to provide some diagnostic ideas for non-invasive diagnosis of lymph node lesions.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTSMIULTRASOUND

Timeline

Start date
2020-09-01
Primary completion
2020-12-30
Completion
2022-12-30
First posted
2021-06-16
Last updated
2021-06-16

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04928560. Inclusion in this directory is not an endorsement.

Diagnosis of Superficial Lymphadenopathy (NCT04928560) · Clinical Trials Directory